1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Watknitz MA, Swiergiel JJ, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147. [
DOI:10.1126/science.282.5391.1145]
2. Carpenter M, Inokuma M, Denham J, Mujtaba T, Chiu CP, Rao M. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol 2001; 172: 383-397. [
DOI:10.1006/exnr.2001.7832]
3. Aflatoonian B, Ruban L, Shamsuddin S, Baker D, Andrews P, Moore H. Generation of Sheffield (Shef) human embryonic stem cell lines using a microdrop culture system. In Vitro Cell Dev Biol Anim 2010; 46: 236-241. [
DOI:10.1007/s11626-010-9294-2]
4. Aflatoonian B, Ruban L, Jones M, Aflatoonian R, Fazeli A, Moore HD. In vitro post-meiotic germ cell development from human embryonic stem cells. Hum Reprod 2009; 24: 3150-3159. [
DOI:10.1093/humrep/dep334]
5. Unger C, Skottman H, Blomberg P, Sirac Dilber M, Hovatta O. Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 2008; 17: 48-53. [
DOI:10.1093/hmg/ddn079]
6. European Commission. Directorate-General for Enterprise and Industry. EudraLex, The Rules Governing Medicinal Products in the European :union:. 19th Ed. Office for Official Publications of the European Communities; 2008.
7. Canham MA, Van Deusen A, Brison DR, De Sousa PA, Downie J, Devito L, et al. The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines. Sci Rep 2015; 5: 17258. [
DOI:10.1038/srep17258]
8. UKSCB e-newsletter January 2017. First hESC Lines to be released for Clinical Use. Available at: http:// www.nibsc.org/asset.ashx? assetid=5233dce1-c23e-4cd7-bcf5-cead6200972a.
9. Hewitt ZA, Amps KJ, Moore HD. Derivation of GMP Raw Materials for Use in Regenerative Medicine: hESC-based Therapies, Progress Toward Clinical Application. Clin Pharmacol Ther 2007; 82: 448-542 [
DOI:10.1038/sj.clpt.6100321]